Download Full Volume - United States Renal Data System

AINCIDENCE OF REPORTED ESRD
Reference section A
Table A.6 A.6 (continued)
Mean age at start of ESRD therapy
by
by
demographic
demographic
characteristics
characteristics & primary
primary
diagnosis
diagnosis
298
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
0-4 1.8 1.6 1.7 1.9 1.9 1.4 1.6 1.6 1.7 1.7 1.7
5-9 7.6 7.8 7.6 7.6 7.9 8.0 7.9 7.6 7.6 7.7 7.6
10-14 12.8 13.0 12.8 12.9 12.8 12.7 12.8 12.6 12.8 12.8 12.8
15-19 17.7 17.7 17.7 17.8 17.7 17.7 17.8 17.8 17.8 17.8 17.7
20-29 25.8 25.8 25.8 25.8 25.9 25.9 25.8 25.9 25.8 25.7 25.6
30-39 35.4 35.4 35.5 35.5 35.5 35.5 35.6 35.5 35.5 35.6 35.5
40-49 45.2 45.3 45.3 45.4 45.4 45.4 45.5 45.5 45.5 45.6 45.5
50-59 55.3 55.3 55.3 55.3 55.3 55.2 55.2 55.2 55.2 55.3 55.2
60-64 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.5 62.5
65-69 67.5 67.5 67.5 67.5 67.5 67.5 67.6 67.5 67.5 67.6 67.5
70-79 74.5 74.5 74.6 74.6 74.7 74.8 74.9 74.9 74.9 74.9 75.0
80+ 83.8 83.8 83.9 84.0 84.1 84.2 84.3 84.3 84.3 84.3 84.4
0-19 12.7 13.0 12.9 12.9 12.9 12.8 13.0 12.7 12.7 12.7 12.8
20-44 35.4 35.4 35.7 35.9 35.9 36.0 36.1 36.1 36.1 36.2 36.2
45-64 56.2 56.1 56.1 56.1 56.1 56.0 56.0 56.0 56.0 56.0 56.0
65-74 69.9 70.0 70.0 70.1 70.1 70.1 70.1 70.1 70.1 70.1 70.1
75+ 80.2 80.2 80.3 80.4 80.5 80.6 80.7 80.8 80.9 81.0 81.1
Male 58.6 59.1 59.2 60.1 60.7 60.9 61.4 61.4 61.6 62.1 62.1
Female 60.5 60.9 61.2 61.6 62.3 62.4 62.6 63.0 63.1 63.6 63.5
Unknown 53.0 58.5 58.7 67.3 . . 42.7 39.8 . 57.9 64.7
White 61.3 61.9 62.2 62.8 63.4 63.6 64.0 64.2 64.4 64.9 64.9
Black 56.0 56.2 56.2 56.8 57.5 57.8 57.7 58.2 58.4 58.6 58.6
Native American 57.2 55.8 56.1 56.1 57.6 57.1 57.6 58.0 56.4 57.4 58.0
Asian 57.5 59.2 60.1 61.0 60.3 61.2 61.8 61.4 61.3 62.2 62.5
Other/unknown 52.7 51.1 56.9 57.2 57.7 56.2 56.9 55.5 55.1 54.7 53.8
†Hispanic 57.9 58.1 58.4 58.8 58.4 58.4 58.7 58.7
†Non-Hispanic 61.2 61.9 62.0 62.4 62.7 62.8 63.3 63.3
Diabetes 59.9 60.3 60.9 61.6 62.0 62.3 62.6 62.8 63.0 63.3 63.2
Hypertension 65.0 65.1 65.4 65.8 66.5 66.6 66.9 67.1 67.1 67.6 67.5
Glomerulonephritis 52.1 53.2 53.0 53.8 53.8 53.7 54.3 53.8 53.5 54.1 53.8
Cystic kidney 54.3 55.1 54.2 54.8 55.0 54.6 55.1 55.1 54.9 55.3 54.4
Other urologic 57.5 58.2 59.4 61.1 60.7 61.4 61.5 62.2 62.1 61.6 63.0
Other cause 52.2 52.8 53.2 53.7 54.8 55.1 55.0 55.7 55.9 56.9 56.9
Unknown cause 57.6 58.8 61.1 61.4 62.9 62.4 63.4 63.2 63.1 63.0 63.2
Missing disease 59.8 49.8 50.6 49.6 51.2 50.1 49.1 49.7 48.7 55.7 55.4
U.S. 59.6 60.0 60.2 60.8 61.5 61.7 62.0 62.2 62.3 62.8 62.8
U.S. territories 56.4 55.5 54.9 55.7 55.9 57.4 58.8 58.6 58.8 56.9 58.0
Puerto Rico 58.8 58.4 58.0 59.5 60.5 59.6 60.9 60.1 60.6 60.7 61.1
Foreign 45.1 48.4 48.5 48.9 51.1 53.0 61.0 54.9 63.9 58.0 71.8
Unknown 48.4 48.2 47.0 36.6 41.7 44.1 36.2 44.1 40.7 38.1 41.1
All 59.5 59.9 60.1 60.8 61.4 61.6 62.0 62.2 62.3 62.8 62.7
The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.
The age of the incident patient is determined as of the date of ESRD initiation.
Patients with unknown age are excluded.
†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.
"." Zero values in this cell.